title: [Triple-therapy treatment during 1 month versus 2 weeks in gastroduodenal disease due to Helicobacter pylori in children].
abstract: The aim of this study was to assess the clinical outcome of two different durations of triple therapy in children with Helicobacter pylori infection. We established two treatment groups: 1) Short treatment, including 2 week of bismuth subcitrate, amoxycillin and metronidazole treatment (n = 21) and 2) Long treatment, which included the same therapy for two weeks plus bismuth subcitrate alone for two weeks more (n = 26). We found no difference between the short and long treatments. The infection remained in 14% and 19%, respectively. In both groups, we observed children (19%) with persistent abdominal pain in spite of Helicobacter pylori eradication and gastritis healing. We conclude that it is not necessary to prolong triple therapy more than 2 weeks in order to have therapeutic success.
authors.affiliation: Servicio de Pediatría, Hospital Severo Ochoa, Leganés, Madrid.
authors.forename: M L
authors.initials: ML
authors.lastname: Cilleruelo Pascual
authors.forename: P
authors.initials: P
authors.lastname: Urruzuno Tellería
authors.forename: E
authors.initials: E
authors.lastname: Román Riechman
authors.forename: E
authors.initials: E
authors.lastname: Medina Benítez
authors.forename: J
authors.initials: J
authors.lastname: Manzanares López-Manzanares
authors.forename: F
authors.initials: F
authors.lastname: Echávarri Olavarría
authors.forename: M
authors.initials: M
authors.lastname: Molina Arias
mesh_terms: D000293:Adolescent; D000658:Amoxicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001729:Bismuth / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004382:Duodenitis / Q000188:drug therapy*; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D009942:Organometallic Compounds / Q000008:administration & dosage; D010406:Penicillins / Q000008:administration & dosage; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D009942:Organometallic Compounds; D010406:Penicillins; D008795:Metronidazole; D000658:Amoxicillin; C002791:bismuth tripotassium dicitrate; D001729:Bismuth